Sinovac to Expand Production of COVID-19 Vaccine to 2 Billion Doses

Sinovac Biotech of Beijing plans to start a second manufacturing line for CoronaVac, the company's inactivated COVID-19 vaccine, with the goal of producing two billion doses this year. CoronaVac is approved for emergency use in China , Indonesia , Brazil and Chile . Sinovac has announced various efficacy rates from clinical trials in several countries outside of China. The company insists the vaccine is 100% effective against serious forms of COVID-19, though it is less so against mild or medium-severity cases. More details.... Share this with colleagues: // //